Microdosimetry of astatine-211 single-cell irradiation: Role of daughter polonium-211 diffusion

Medical Physics

Volumn 31, Issue 2, 2004, Pages 218-225

  Palm, Stig ^a   Humm, John L ^a   Rundqvist, Robert ^b   Jacobsson, Lars ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alpha particles; Astatine 211; Diffusion; Microdosimetry; Polonium 211

Indexed keywords

ALPHA PARTICLES; ASTATINE; ATOMS; CELL CULTURE; CELL MEMBRANES; DIFFUSION; IRRADIATION; POISSON DISTRIBUTION; POLONIUM;

CELL SURFACES; ENERGY DEPOSITIONS; EVENT NUMBERS; INDIVIDUAL CELLS; MICRO-DOSIMETRY; PROBABILITY OF SURVIVAL; SINGLE-CELL SUSPENSIONS; SPECIFIC ENERGY;

MONTE CARLO METHODS;

ASTATINE 211; POLONIUM; POLONIUM 211; UNCLASSIFIED DRUG;

ALPHA RADIATION; ARTICLE; CALCULATION; CELL NUCLEUS; CELL SURFACE; CELL SURVIVAL; DISPERSION; HUMAN; HUMAN CELL; IRRADIATION; MICRODOSIMETRY; MONTE CARLO METHOD; POISSON DISTRIBUTION; PRIORITY JOURNAL; PUBLICATION; RADIOSENSITIVITY; SIMULATION;

EID: 1242344875     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1640951     Document Type: Article

References (35)

1. S. K. Imam, "Advancements in cancer therapy with alpha-emitters: A review," Int. J. Radiat. Oncol., Biol., Phys. 51, 271-278 (2001).
2. M. R. McDevitt, D. Ma, L. T. Lai, J. Simon, P. Borchardt, R. K. Frank, K. Wu, V. Pellegrini, M. J. Curcio, M. Miederer, N. H. Bander, and D. A. Scheinberg, "Tumor therapy with targeted atomic nonogenerators," Science 294, 1537-1540 (2001).
3. G. Vaidyanathan and M. R. Zalutsky, "Targeted therapy using alpha emitters," Phys. Med. Biol. 41, 1915-1931 (1996).
4. E. Aurlien, R. H. Larsen, G. Akabani, D. R. Olsen, M. R. Zalutsky, and Ø. S. Bruland, "Exposure of human osteosarcoma and bone marrow cells to tumour-targeted α-particles and γ-irradiation: Analysis of cell survival and microdosimetry," Int. J. Radiat. Biol. 76, 1129-1141 (2000).
5. E. Aurlien, Y Kvinnsland, R. H. Larsen, and Ø. S. Bruland. Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an α-emitting radioimmunoconjugate and external γ-irradiation," Int. J. Radiat. Biol. 78, 133-142 (2000).
6. 211At]astato-2′-deoxyuridine in human cancer cells," Int. J. Radiat. Biol. 72, 79-90 (1997).
7. R. H. Larsen, G. Akabani, P. Welsh, and M. R. Zalutsky, "The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro," Radiat. Res. 149, 155-162 (1998).
8. S. Palm, T. Bäck, I. Claesson, U. Delle, R. Hultbom, L. Jacobsson, I. Köpf, and S. Lindegren, "Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay," Anticancer Res. 18, 1671-1676 (1998).
9. 211At-monoclonal antibody compared to external irradiation for two human cancer cell lines," Anticancer Res. 20, 1005-1012 (2000).
10. M. A. Walicka, G. Vaidyanathan, M. R. Zalutsky, S. J. Adelstein, and A. I. Kassis, "Survival and DNA damage in chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorprated astatine-211," Radiat. Res. 150, 263-268 (1998).
11. T. R. Munro, "The relative radiosensitivity of the nucleus and cytoplasms of Chinese hamster fibroblasts," Radiat. Res. 42, 451-470 (1970).
12. W. C. Roesch, "Microdosimetry of internal sources," Radiat. Res. 70, 494-510 (1977).
13. T. G. Stinchcomb and J. C. Roeske, "Analytic microdosimetry for radioimmunotherapeutic alpha emitters," Med. Phys. 19, 1385-1393 (1992).
14. T. G. Stinchcomb and J. C. Roeske, "Survival of alpha particle irradiated cells as a function of the shape and size of the sensitive volume (nucleus)," Radiat. Prot. Dosim. 62, 157-164 (1995).
15. J. C. Roeske and T. G. Stinchcomb, "The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters," Radiat. Res. 151, 31-38 (1999).
16. M. Bardies and M. J. Myers, "A simplified approach to alpha dosimetry for small spheres labelled on the surface," Phys. Med. Biol. 35, 1551-1561 (1990).
17. J. L. Humm, "A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy," Int. J. Radiat. Oncol., Biol., Phys. 13, 1767-1773 (1987).
18. J. L. Humm and L. M. Cobb, "Nonuniformity of tumor dose in radioimmunotherapy," J. Nucl. Med. 31, 75-83 (1990).
19. J. L. Humm and L. M. Chin, "A model of cell inactivation by alpha-particle internal emitters," Radiat. Res. 134, 143-150 (1993).
20. J. C. Roeske, G. T. Chen, R. W. Atcher, C. A. Pelizzari, J. Rotmensch, D. Haraf, A. Montag, and R. R. Weichselbaum, "Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters," Int. J. Radiat. Oncol., Biol., Phys. 19, 1539-1548 (1990).
21. J. L. Humm, R. M. Macklis, K. Bump, L. M. Cobb, and L. M. Chin, "Internal dosimetry using data derived from autoradiographs," J. Nucl. Med. 34, 1811-1817 (1993).
22. G. Akabani and M. R. Zalutsky, "Microdosimetry of astatine-211 using histological images: Application to bone marrow," Radiat. Res. 148, 599-607 (1997).
23. D. E. Charlton, T. D. Utteridge, and B. J. Allen, "Theoretical treatment of human haemopoietic stem cell survival following irradiation by alpha particles," Int. J. Radiat. Biol. 74, 111-118 (1998).
24. 211At appended to the cell surfaces," Radiat. Res. 151, 750-753 (1999).
25. 211At]astatine-labeled C215 monoclonal antibody: Improved estimates of radiosensitivity from measurements on cellular uptake and retention," Anticancer Res. 23, 1219-1222 (2003).
26. G. W. Barendsen, T. L. J. Beusker, A. J. Vergroesen, and L. Budke, "Effects of different ionizing radiations on human cells in tissue culture," Radiat. Res. 13, 841-849 (1960).
27. International Commission on Radiation Units and Measurements, Report 36, "Microdosimetry," ICRU, Bethesda, MD, 1983.
28. 125I-labelled internalized and non-internalized monoclonal antibodies in nude mice with human colon carcinoma xenografts," Nucl. Med. Biol. 20, 133-144 (1993).
29. C. Crowe, M. Sommerfeld, and Y. Tsuji, Multiphase Flows with Droplets and Particles (CRC, Boca Raton, FL, 1998).
30. D. J. Tritton, Physical Fluid Dynamics (Clarendon, Oxford, 1988).
31. International Commission on Radiation Units and Measurements, Report 49, "Stopping powers and ranges for protons and alpha particles," ICRU, Bethesda, MD, 1993.
32. D. A. Weber, K. F. Eckerman, L. T. Dillman, and J. Ryman, MIRD-Radionuclide Data and Decay Schemes (The Society of Nuclear Medicine, New York, 1989).
33. G. E. P. Box and M. E. Muller, "A note on the generation of random normal deviates," Ann. Math. Stat. 29, 610-611 (1958).
34. 211At]astatobenzylguanidine on human neuroblastoma cells," Cancer Res. 54, 5414-5419 (1994).
35. K. A. Hamacher, R. B. Den, E. I. Den, and G. Sgouros, "Cellular dose conversion factors for alpha-particle-emitting radionuclides of interest in radionuclide therapy," J. Nucl. Med. 42, 1216-1221 (2001).